The Current Ratio as of December 2024 (TTM) for Champions Oncology, Inc. (CSBR) is 0.75

According to Champions Oncology, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.75. This represents a change of 11.94% compared to the average of 0.67 of the last 4 quarters.

Champions Oncology, Inc. (CSBR) Historical Current Ratio (quarterly & annually)

How has CSBR Current Ratio performed in the past?

The mean historical Current Ratio of Champions Oncology, Inc. over the last ten years is 1.10. The current 0.75 Current Ratio has changed 6.69% with respect to the historical average. Over the past ten years (40 quarters), CSBR's Current Ratio was at its highest in in the April 2015 quarter at 2.84. The Current Ratio was at its lowest in in the January 2015 quarter at 0.24.

Champions Oncology, Inc. (CSBR) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Champions Oncology, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Champions Oncology, Inc. (CSBR) Average Current Ratio

How has CSBR Current Ratio performed in the past?

The current Current Ratio of Champions Oncology, Inc. (CSBR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Champions Oncology, Inc. (CSBR) Current Ratio vs. Peers

How is CSBR’s Current Ratio compared to its peers?

Champions Oncology, Inc.’s Current Ratio is less than Molecular Partners AG (14.33), less than MediciNova, Inc. (16.66), less than Anebulo Pharmaceuticals, Inc. (3.45), less than Cyteir Therapeutics, Inc. (21.89), less than Pardes Biosciences, Inc. (9.81), less than Shattuck Labs, Inc. (7.96), less than Eliem Therapeutics, Inc. (0), less than Century Therapeutics, Inc. (10.39), less than Aerovate Therapeutics, Inc. (8.78), less than Adagene Inc. (2.50), less than Acrivon Therapeutics, Inc. Common Stock (12.75), less than Rezolute, Inc. (13.79), less than AN2 Therapeutics, Inc. (9.75), greater than HCW Biologics Inc. (0.07),

Build a custom stock screener for Champions Oncology, Inc. (CSBR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Champions Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Champions Oncology, Inc. (CSBR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Champions Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.